Howard Capital Management’s Verastem VSTM Stock Holding History

Howard Capital Management’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-833	Closed	-$14K	–	42
2022 Q1	$14K	Buy	+833	New	+$14.3K	﹤0.01%	40

Other funds holding VSTM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Howard Capital Management's VSTM Position: Q2 2022 in Review

Howard Capital Management sold out of Verastem (VSTM) in Q2 2022, closing a stake of 833 shares — an estimated $14K sold.

Howard Capital Management first reported a position in VSTM in Q1 2022 and held it in 1 quarter. The position peaked at $14K in Q1 2022. 122 funds tracked by Wall St. Rank hold VSTM as of Q2 2022.

Howard Capital Management reported no remaining Verastem position as of Q2 2022 after selling out during the quarter.
Howard Capital Management sold 833 Verastem shares in Q2 2022, an estimated $14K.
Howard Capital Management first reported a position in Verastem in Q1 2022 and held it in 1 quarter.
Howard Capital Management's Verastem position peaked at $14K in Q1 2022.
122 funds tracked by Wall St. Rank held Verastem as of Q2 2022.

Based on Howard Capital Management's 13F filing for Q2 2022, filed 27 Jul 2022.